The role of cytokines in MET-enkephalin-modulated nitric oxide release.
In the present study the in vitro and in vivo effect of Met-enkephalin (MENK) on nitric oxide (NO) release by mouse peritoneal macrophages was evaluated. While in vitro MENK was ineffective unless combined with suboptimal concentrations of recombinant murine interferon gamma, in vivo all the doses (2.5, 5 or 10 mg/kg bw) bimodaly modulated NO release. Only the stimulative (2.5 and 10 mg/kg bw) and not the suppressive (5 mg/kg bw) dose of MENK was opioid receptor-mediated as demonstrated by abolishing the effect by naloxone. The stimulative effect of the low (2.5 mg/kg bw) dose, that was observed only if MENK was injected p.m., was associated with the IL production and IFN gamma as demonstrated by abolishing the effect by specific antibodies. The data additionally support the idea that opioid-mediated responses might be to a large degree mediated by the release of cytokines.
Marotti
T
T
Department of Biology and Medicine, Ruder Bosković Institute, Zagreb, Croatia.
Balog
T
T
Mazuran
R
R
Rocić
B
B
D000818:Animals; D002478:Cells, Cultured; D016207:Cytokines / Q000502:physiology*; D004744:Enkephalin, Methionine / Q000008:administration & dosage / Q000494:pharmacology*; D007371:Interferon-gamma / Q000494:pharmacology; D007375:Interleukin-1 / Q000378:metabolism; D017737:Macrophages, Peritoneal / Q000378:metabolism*; D008297:Male; D051379:Mice; D008808:Mice, Inbred CBA; D009270:Naloxone / Q000494:pharmacology; D009292:Narcotic Antagonists / Q000494:pharmacology; D009569:Nitric Oxide / Q000378:metabolism*; D011994:Recombinant Proteins
D016207:Cytokines; D007375:Interleukin-1; D009292:Narcotic Antagonists; D011994:Recombinant Proteins; D009569:Nitric Oxide; D009270:Naloxone; D004744:Enkephalin, Methionine; D007371:Interferon-gamma